Search trials for
Showing NN of NN trials
Enrolling

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablati...

The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX Device is...

Enrolling

Global Anticoagulant Registry in the Field

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a pioneering real-world prospective registry - one of the...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical...

Multi-center, single-arm, prospective, post-market study of LAmbre™ LAA Closure System. To evaluate immediate and long term procedural success of Lifetech...

Enrolling

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With...

Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to demonstrate the safety and effectiveness when compared to an...

Enrolling

Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillat...

The aim of the study is to estimate the contribution of abdominal imaging by magnetic resonance Imaging (MRI) and abdominal...

Not Yet Enrolling

Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF...

Atrial fibrillation (AF) remains a significant contributor to cardiovascular morbidity. Amiodarone is a potent antiarrhythmic drug; however, patients receiving IV...

Not Yet Enrolling

WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusio...

WATCH-Rhythm is a prospective, randomized, multi-center, investigation to collect safety and effectiveness data on combining conventional AF ablation with LAA...

Not Yet Enrolling

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under...

To characterize and analyze the number, type and incidence of adverse events/suspected adverse drug reactions in patients treated with Apixaban,...